Indigotindisulfonate Sodium Patent Expiration

Indigotindisulfonate Sodium was first introduced by Provepharm Sas in its drug Bludigo on Jul 8, 2022.


Indigotindisulfonate Sodium Patents

Given below is the list of patents protecting Indigotindisulfonate Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bludigo US10927258 Process for the preparation of Indigotindisulfonate sodium (indigo carmine) Dec 23, 2037 Provepharm Sas
Bludigo US11499050 Process for the preparation of indigotindisulfonate sodium (indigo carmine) Dec 23, 2037 Provepharm Sas
Bludigo US11845867 Process for the preparation of indigotindisulfonate sodium (indigo carmine) Nov 25, 2036 Provepharm Sas



Indigotindisulfonate Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List